Current Cases

Truvada/TDF lawsuit

TDF drugs are antiretrovirals used to treat HIV.  Gilead Sciences markets TDF in combination with other drugs under the brand name Truvada, as well as other names such as Atripla, Complera, Stribild, Symfi-Lo, Cimduo and Viread. Studies have found TDF drugs to be damaging to the kidneys and bones—dangers that were not properly disclosed to patients by Gilead. More…

Proton Pump Inhibitors (PPIs) and kidney disease

Millions of Americans have taken PPIs like Prilosec, Nexium and Prevacid to treat heartburn. These drugs have been promoted as a safe and more effective alternative to other antacid treatments and have been widely prescribed. These drugs, however, can allegedly cause extensive kidney damage. Numerous studies have shown the potential for injury from PPI use, and drug manufacturers have been required to add and strengthen product label warnings. More…

Incretin Mimetics and pancreatic complications

Incretin mimetics are a class of drugs used to Type 2 diabetes. Recent studies have shown that incretin mimetics are linked with pancreatic cancer. In 2013, the FDA released unpublished academic research that demonstrated pre-cancerous cellular changes known as pancreatic duct metaplasia in Type 2 diabetic patients treated with incretin mimetics. More…

Pradaxa and internal bleeding

Pradaxa is an anticoagulant prescription medication used to prevent strokes in atrial fibrillation patients. Unfortunately, tens of thousands of adverse events have resulted from use of Pradaxa, particularly bleeding events that required transfusions or hospitalization. More…

Taxotere and permanent hair loss

Taxotere is a plant alkaloid chemotherapy drug derived from the yew tree. Taxotere is used intravenously in patients with locally advanced or metastatic breast cancer (after failure of prior chemotherapy) and in conjunction with doxorubicin and cyclophosphamide in patients with operable node-positive breast cancer. More…

Valsartan and cancer, liver damage

Valsartan is an angiotensin-receptor blocker which is prescribed to patients with high blood pressure or congestive heart failure. Valsartan is widely manufactured overseas. Unfortunately, the Food and Drug Administration (FDA) has found Valsartan drugs made by generic manufacturers to be contaminated with N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA). These impurities may have the potential to cause cancer and/or serious liver damage. More…

Xeljanz and pulmonary embolism and pulmonary thrombosis

Xeljanz is a drug used to treat rheumatoid arthritis and ulcerative colitis. Unfortunately, after Xeljanz was approved the FDA issued a safety warning on the drug, regarding an increased risk of blood clots and of death with the 10 mg twice daily dose of Xeljanz. More…

Lemtrada and stroke

 Lemtrada is an intravenous medication used to treat multiple sclerosis. Since it was approved, patients have been suffering from strokes and arterial dissection. Adverse events prompted the FDA to issue a Drug Safety Communication warning of risk of strokes and tears in lining of arteries of the head and neck in MS patients who are administered Lemtrada, mandating a boxed warning, the most serious type of label warning. More…

Provigil, Nuvigil and birth defects

Provigil and Nuvigil are indicated to improve wakefulness in adults who experience excessive sleepiness that may accompany obstructive sleep apnea, narcolepsy, or “shift work disorder.” The drugs’ manufacturer, Teva, announced several significant birth defects that are possible if a woman takes either of these drugs during pregnancy. More…

Roundup and non-Hodgkin lymphoma

Roundup is the best-selling weed-killer in the world, used regularly by farm workers and landscapers. Roundup has recently been linked to non-Hodgkin lymphoma and leukemia. There are currently thousands of lawsuits faced by Bayer/Monsanto alleging Roundup caused cancer, and that Monsanto knew of this risk but failed to properly warn individuals of this danger. More…

Uloric and cardiovascular injury

Uloric is a gout drug that works by lowering the uric acid level in the blood stream. The FDA has required a new box warning for Uloric after it “found an increased risk of heart-related death and death from all causes” in patients who take the drug. More…